A multicentre, randomized, open label study comparing the concomitant administration of trabectedin and low-dose radiotherapy versus trabectedin alone in patients with advanced sarcoma
Sponsor: Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
Phase: 4
Disease: Soft tissue sarcoma, Liposarcoma, Leiomyosarcoma
EU trial number: 2026-525703-27-00
Population: Adults aged 18–75 years with centrally confirmed, measurable, progressive advanced or metastatic soft tissue sarcoma that is unresectable or unsuitable for metastasectomy. Participants must have received one to three prior systemic treatment lines for advanced disease, have ECOG performance status 0–1, and be eligible for systemic chemotherapy and protocol radiotherapy.
Register Investigator Interest
Interested in offering this trial to suitable patients?